应交易所要求,美/港股行情延时15分钟展示,下载APP即可免费查看实时行情。
关闭
INSM Insmed
已收盘 07-10 16:00:00 EDT
96.66
+0.19
+0.20%
盘后
96.89
+0.23
+0.24%
19:14 EDT
最高
98.00
最低
95.27
成交量
176.07万
今开
96.55
昨收
96.47
日振幅
2.84%
总市值
183.38亿
流通市值
181.25亿
总股本
1.90亿
成交额
1.70亿
换手率
0.94%
流通股本
1.88亿
市净率
184.93
ROE
-890.75%
每股收益
-5.89
52周最高
106.83
52周最低
60.40
市盈率
-16.42
股息
0.00
股息收益率
0.00
ROA
-36.25%
分时
五日
日K
周K
月K
数据加载中...
北京优虎网络科技有限公司
资讯
新帖
简况
Insmed Incorporated7月9日成交额为2.62亿美元
市场透视 · 07-10 02:50
Insmed Incorporated7月9日成交额为2.62亿美元
Insmed Incorporated7月8日成交额为1.85亿美元
市场透视 · 07-09 02:49
Insmed Incorporated7月8日成交额为1.85亿美元
Insmed Incorporated7月7日成交额为2.40亿美元
市场透视 · 07-08 02:47
Insmed Incorporated7月7日成交额为2.40亿美元
Insmed Incorporated7月3日成交额为1.71亿美元
市场透视 · 07-04
Insmed Incorporated7月3日成交额为1.71亿美元
Insmed Incorporated7月2日成交额为3.26亿美元
市场透视 · 07-03
Insmed Incorporated7月2日成交额为3.26亿美元
Insmed Incorporated7月1日成交额为3.78亿美元
市场透视 · 07-02
Insmed Incorporated7月1日成交额为3.78亿美元
Insmed Incorporated6月30日成交额为4.28亿美元
市场透视 · 07-01
Insmed Incorporated6月30日成交额为4.28亿美元
Insmed Incorporated6月27日成交额为34.39亿美元
市场透视 · 06-28
Insmed Incorporated6月27日成交额为34.39亿美元
Insmed Incorporated6月25日成交额为3.71亿美元
市场透视 · 06-26
Insmed Incorporated6月25日成交额为3.71亿美元
Insmed Incorporated6月24日成交额为4.68亿美元
市场透视 · 06-25
Insmed Incorporated6月24日成交额为4.68亿美元
Insmed Incorporated6月20日成交额为4.75亿美元
市场透视 · 06-21
Insmed Incorporated6月20日成交额为4.75亿美元
Insmed Incorporated6月18日成交额为2.26亿美元
市场透视 · 06-19
Insmed Incorporated6月18日成交额为2.26亿美元
Insmed Incorporated6月13日成交额为5.23亿美元
市场透视 · 06-14
Insmed Incorporated6月13日成交额为5.23亿美元
Insmed Incorporated6月11日成交额为12.29亿美元
市场透视 · 06-12
Insmed Incorporated6月11日成交额为12.29亿美元
加拿大皇家银行:维持Insmed(INSM.US)评级,由优于大市调整至优于大市评级, 目标价由99.00美元调整至106.00美元。
金融界 · 06-11
加拿大皇家银行:维持Insmed(INSM.US)评级,由优于大市调整至优于大市评级, 目标价由99.00美元调整至106.00美元。
HC Wainwright & Co.:维持Insmed(INSM.US)评级,由买入调整至买入评级, 目标价由90.00美元调整至120.00美元。
金融界 · 06-11
HC Wainwright & Co.:维持Insmed(INSM.US)评级,由买入调整至买入评级, 目标价由90.00美元调整至120.00美元。
Insmed Incorporated6月10日成交额为14.13亿美元
市场透视 · 06-11
Insmed Incorporated6月10日成交额为14.13亿美元
Leerink Partners:维持Insmed(INSM.US)评级,由优于大市调整至优于大市评级, 目标价由100.00美元调整至115.00美元。
金融界 · 06-10
Leerink Partners:维持Insmed(INSM.US)评级,由优于大市调整至优于大市评级, 目标价由100.00美元调整至115.00美元。
Insmed Incorporated6月3日成交额为1.38亿美元
市场透视 · 06-04
Insmed Incorporated6月3日成交额为1.38亿美元
Insmed Incorporated6月2日成交额为1.75亿美元
市场透视 · 06-03
Insmed Incorporated6月2日成交额为1.75亿美元
加载更多
公司概况
公司名称:
Insmed
所属市场:
NASDAQ
上市日期:
2000-06-01
主营业务:
Insmed Incorporated是一家生物制药公司,专注于研发吸入疗法为患者对抗危及生命的肺部疾病。公司主打产品ARIKACE和阿米卡星脂质体吸入剂是一种吸入的抗生疗法,证明抗感染药在治疗肺部重感染疾病时能提升该疗法的效果,安全性阿和便利性。公司于1999年11月29日在英联邦弗吉尼亚州成立。
发行价格:
--
{"stockData":{"symbol":"INSM","market":"US","secType":"STK","nameCN":"Insmed","latestPrice":96.66,"timestamp":1752177600000,"preClose":96.47,"halted":0,"volume":1760697,"hourTrading":{"tag":"盘后","latestPrice":96.89,"preClose":96.66,"latestTime":"19:14 EDT","volume":21015,"amount":2031379.125,"timestamp":1752189250524},"delay":0,"floatShares":187510036,"shares":189712600,"eps":-5.886141,"marketStatus":"已收盘","change":0.19,"latestTime":"07-10 16:00:00 EDT","open":96.55,"high":98,"low":95.265,"amount":170385043.23792002,"amplitude":0.028351,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":-5.886141,"tradingStatus":0,"nextMarketStatus":{"tag":"盘前交易","tradingStatus":1,"beginTime":1752220800000},"marketStatusCode":5,"adr":0,"adrRate":0,"listingDate":959832000000,"exchange":"NASDAQ","adjPreClose":96.47,"preHourTrading":{"tag":"盘前","latestPrice":95.89,"preClose":96.47,"latestTime":"09:26 EDT","volume":4773,"amount":458591.79693,"timestamp":1752154017469},"postHourTrading":{"tag":"盘后","latestPrice":96.89,"preClose":96.66,"latestTime":"19:14 EDT","volume":21015,"amount":2031379.125,"timestamp":1752189250524},"volumeRatio":0.720801,"impliedVol":0.6203,"impliedVolPercentile":0.716},"requestUrl":"/m/hq/s/INSM","defaultTab":"news","newsList":[{"id":"2550606696","title":"Insmed Incorporated7月9日成交额为2.62亿美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2550606696","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2550606696?lang=zh_cn&edition=full","pubTime":"2025-07-10 10:50","pubTimestamp":1752115858,"startTime":"0","endTime":"0","summary":"美东时间2025年7月9日,Insmed Incorporated成交额为2.62亿美元,成交额较昨日增加42.02%,当日成交量为271.15万股。Insmed Incorporated于2025年7月9日涨0.34%,报96.47美元,该股过去5个交易日跌1.18%,年初至今涨39.73%,过去60日涨48.85%。该公司还在开发Brensocatib,一种用于支气管扩张和其他中性粒细胞介导疾病的口服可逆二肽基肽酶1抑制剂以及Treprostinil Palmitil吸入粉剂,一种用于治疗与间质性肺病和肺动脉高压相关的肺动脉高压的吸入性treprostiil前药。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250710105100a44187f9&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250710105100a44187f9&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LU0109394709.USD","LU0053671581.USD","INSM","BK4139","LU0889565916.HKD","LU0320765992.SGD"],"gpt_icon":0},{"id":"2550506911","title":"Insmed Incorporated7月8日成交额为1.85亿美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2550506911","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2550506911?lang=zh_cn&edition=full","pubTime":"2025-07-09 10:49","pubTimestamp":1752029389,"startTime":"0","endTime":"0","summary":"美东时间2025年7月8日,Insmed Incorporated成交额为1.85亿美元,成交额较昨日减少22.91%,当日成交量为191.32万股。Insmed Incorporated于2025年7月8日跌0.84%,报96.14美元,该股过去5个交易日跌4.47%,年初至今涨39.25%,过去60日涨42.32%。该公司还在开发Brensocatib,一种用于支气管扩张和其他中性粒细胞介导疾病的口服可逆二肽基肽酶1抑制剂以及Treprostinil Palmitil吸入粉剂,一种用于治疗与间质性肺病和肺动脉高压相关的肺动脉高压的吸入性treprostiil前药。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250709104959a43f3e3e&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250709104959a43f3e3e&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LU0109394709.USD","LU0320765992.SGD","LU0053671581.USD","LU0889565916.HKD","BK4139","INSM"],"gpt_icon":0},{"id":"2549593363","title":"Insmed Incorporated7月7日成交额为2.40亿美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2549593363","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2549593363?lang=zh_cn&edition=full","pubTime":"2025-07-08 10:47","pubTimestamp":1751942870,"startTime":"0","endTime":"0","summary":"美东时间2025年7月7日,Insmed Incorporated成交额为2.40亿美元,成交额较昨日增加39.79%,当日成交量为248.64万股。Insmed Incorporated于2025年7月7日跌0.87%,报96.95美元,该股过去5个交易日跌2.55%,年初至今涨40.43%,过去60日涨49.22%。该公司还在开发Brensocatib,一种用于支气管扩张和其他中性粒细胞介导疾病的口服可逆二肽基肽酶1抑制剂以及Treprostinil Palmitil吸入粉剂,一种用于治疗与间质性肺病和肺动脉高压相关的肺动脉高压的吸入性treprostiil前药。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250708104758a43cfcf5&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250708104758a43cfcf5&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["INSM","BK4139","LU0053671581.USD","LU0889565916.HKD","LU0109394709.USD","LU0320765992.SGD"],"gpt_icon":0},{"id":"2548251330","title":"Insmed Incorporated7月3日成交额为1.71亿美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2548251330","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2548251330?lang=zh_cn&edition=full","pubTime":"2025-07-04 10:50","pubTimestamp":1751597455,"startTime":"0","endTime":"0","summary":"美东时间2025年7月3日,Insmed Incorporated成交额为1.71亿美元,成交额较昨日减少47.50%,当日成交量为176.24万股。Insmed Incorporated于2025年7月3日跌0.45%,报97.8美元,该股过去5个交易日跌3.87%,年初至今涨41.66%,过去60日涨43.63%。该公司还在开发Brensocatib,一种用于支气管扩张和其他中性粒细胞介导疾病的口服可逆二肽基肽酶1抑制剂以及Treprostinil Palmitil吸入粉剂,一种用于治疗与间质性肺病和肺动脉高压相关的肺动脉高压的吸入性treprostiil前药。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250704105102a4ce7e07&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250704105102a4ce7e07&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["INSM","LU0889565916.HKD","LU0053671581.USD","BK4139","LU0320765992.SGD","LU0109394709.USD"],"gpt_icon":0},{"id":"2548823463","title":"Insmed Incorporated7月2日成交额为3.26亿美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2548823463","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2548823463?lang=zh_cn&edition=full","pubTime":"2025-07-03 10:50","pubTimestamp":1751511030,"startTime":"0","endTime":"0","summary":"美东时间2025年7月2日,Insmed Incorporated成交额为3.26亿美元,成交额较昨日减少13.56%,当日成交量为334.00万股。Insmed Incorporated于2025年7月2日涨0.64%,报98.24美元,该股过去5个交易日跌6.3%,年初至今涨42.29%,过去60日涨42.01%。该公司还在开发Brensocatib,一种用于支气管扩张和其他中性粒细胞介导疾病的口服可逆二肽基肽酶1抑制剂以及Treprostinil Palmitil吸入粉剂,一种用于治疗与间质性肺病和肺动脉高压相关的肺动脉高压的吸入性treprostiil前药。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250703105039a72bb628&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250703105039a72bb628&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","LU0320765992.SGD","INSM","LU0889565916.HKD","LU0109394709.USD","LU0053671581.USD"],"gpt_icon":0},{"id":"2548534998","title":"Insmed Incorporated7月1日成交额为3.78亿美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2548534998","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2548534998?lang=zh_cn&edition=full","pubTime":"2025-07-02 10:48","pubTimestamp":1751424521,"startTime":"0","endTime":"0","summary":"美东时间2025年7月1日,Insmed Incorporated成交额为3.78亿美元,成交额较昨日减少11.78%,当日成交量为384.13万股。Insmed Incorporated于2025年7月1日跌3.0%,报97.62美元,该股过去5个交易日跌7.82%,年初至今涨41.4%,过去60日涨33.12%。该公司还在开发Brensocatib,一种用于支气管扩张和其他中性粒细胞介导疾病的口服可逆二肽基肽酶1抑制剂以及Treprostinil Palmitil吸入粉剂,一种用于治疗与间质性肺病和肺动脉高压相关的肺动脉高压的吸入性treprostiil前药。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250702104844a7298e9a&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250702104844a7298e9a&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LU0889565916.HKD","LU0320765992.SGD","INSM","BK4139","LU0053671581.USD","LU0109394709.USD"],"gpt_icon":0},{"id":"2548023397","title":"Insmed Incorporated6月30日成交额为4.28亿美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2548023397","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2548023397?lang=zh_cn&edition=full","pubTime":"2025-07-01 10:39","pubTimestamp":1751337580,"startTime":"0","endTime":"0","summary":"美东时间2025年6月30日,Insmed Incorporated成交额为4.28亿美元,成交额较昨日减少87.55%,当日成交量为425.41万股。Insmed Incorporated于2025年6月30日涨1.16%,报100.64美元,该股过去5个交易日跌4.53%,年初至今涨45.77%,过去60日涨37.04%。|近5个交易日成交情况||||#|日期|成交额(美元)|成交额较昨日变化|成交量(股)|#|2025-06-30|4.28亿|-87.55%|425.41万|#|2025-06-27|34.39亿|744.96%|3448.78万|#|2025-06-26|4.07亿|9.60%|395.71万|#|2025-06-25|3.71亿|-20.71%|353.09万|#|2025-06-24|4.68亿|28.27%|443.26万|Insmed Inc是一家生物制药公司,致力于改变患有严重和罕见疾病的患者的生活。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250701103944a72758cf&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250701103944a72758cf&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LU0320765992.SGD","LU0053671581.USD","LU0889565916.HKD","BK4139","INSM","LU0109394709.USD"],"gpt_icon":0},{"id":"2546766773","title":"Insmed Incorporated6月27日成交额为34.39亿美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2546766773","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2546766773?lang=zh_cn&edition=full","pubTime":"2025-06-28 10:51","pubTimestamp":1751079063,"startTime":"0","endTime":"0","summary":"美东时间2025年6月27日,Insmed Incorporated成交额为34.39亿美元,成交额较昨日增加744.96%,当日成交量为3448.78万股。Insmed Incorporated于2025年6月27日跌2.21%,报99.49美元,该股过去5个交易日跌3.11%,年初至今涨44.1%,过去60日涨38.18%。该公司还在开发Brensocatib,一种用于支气管扩张和其他中性粒细胞介导疾病的口服可逆二肽基肽酶1抑制剂以及Treprostinil Palmitil吸入粉剂,一种用于治疗与间质性肺病和肺动脉高压相关的肺动脉高压的吸入性treprostiil前药。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250628105105a4c24f48&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250628105105a4c24f48&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LU0109394709.USD","LU0320765992.SGD","INSM","LU0889565916.HKD","LU0053671581.USD","BK4139"],"gpt_icon":0},{"id":"2546271438","title":"Insmed Incorporated6月25日成交额为3.71亿美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2546271438","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2546271438?lang=zh_cn&edition=full","pubTime":"2025-06-26 10:53","pubTimestamp":1750906417,"startTime":"0","endTime":"0","summary":"美东时间2025年6月25日,Insmed Incorporated成交额为3.71亿美元,成交额较昨日减少20.71%,当日成交量为353.09万股。Insmed Incorporated于2025年6月25日跌0.99%,报104.85美元,该股过去5个交易日涨4.56%,年初至今涨51.87%,过去60日涨34.44%。该公司还在开发Brensocatib,一种用于支气管扩张和其他中性粒细胞介导疾病的口服可逆二肽基肽酶1抑制剂以及Treprostinil Palmitil吸入粉剂,一种用于治疗与间质性肺病和肺动脉高压相关的肺动脉高压的吸入性treprostiil前药。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250626105341a71e0ebf&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250626105341a71e0ebf&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["INSM","BK4139","LU0320765992.SGD","LU0889565916.HKD","LU0109394709.USD","LU0053671581.USD"],"gpt_icon":0},{"id":"2546664942","title":"Insmed Incorporated6月24日成交额为4.68亿美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2546664942","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2546664942?lang=zh_cn&edition=full","pubTime":"2025-06-25 10:50","pubTimestamp":1750819846,"startTime":"0","endTime":"0","summary":"美东时间2025年6月24日,Insmed Incorporated成交额为4.68亿美元,成交额较昨日增加28.27%,当日成交量为443.26万股。Insmed Incorporated于2025年6月24日涨0.46%,报105.9美元,该股过去5个交易日涨4.24%,年初至今涨53.39%,过去60日涨36.31%。该公司还在开发Brensocatib,一种用于支气管扩张和其他中性粒细胞介导疾病的口服可逆二肽基肽酶1抑制剂以及Treprostinil Palmitil吸入粉剂,一种用于治疗与间质性肺病和肺动脉高压相关的肺动脉高压的吸入性treprostiil前药。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250625105047a71c3427&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250625105047a71c3427&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","LU0889565916.HKD","LU0109394709.USD","INSM","LU0320765992.SGD","LU0053671581.USD"],"gpt_icon":0},{"id":"2545104968","title":"Insmed Incorporated6月20日成交额为4.75亿美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2545104968","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2545104968?lang=zh_cn&edition=full","pubTime":"2025-06-21 10:49","pubTimestamp":1750474183,"startTime":"0","endTime":"0","summary":"美东时间2025年6月20日,Insmed Incorporated成交额为4.75亿美元,成交额较昨日增加110.13%,当日成交量为466.89万股。Insmed Incorporated于2025年6月20日涨3.24%,报102.68美元,该股过去5个交易日涨5.99%,年初至今涨48.73%,过去60日涨30.74%。|近5个交易日成交情况||||#|日期|成交额(美元)|成交额较昨日变化|成交量(股)|#|2025-06-20|4.75亿|110.13%|466.89万|#|2025-06-18|2.26亿|-16.35%|226.92万|#|2025-06-17|2.70亿|-39.86%|268.47万|#|2025-06-16|4.49亿|-14.14%|447.88万|#|2025-06-13|5.23亿|-26.43%|532.16万|Insmed Inc是一家生物制药公司,致力于改变患有严重和罕见疾病的患者的生活。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250621104946a4b5a089&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250621104946a4b5a089&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LU0053671581.USD","BK4139","LU0320765992.SGD","INSM","LU0109394709.USD","LU0889565916.HKD"],"gpt_icon":0},{"id":"2544064133","title":"Insmed Incorporated6月18日成交额为2.26亿美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2544064133","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2544064133?lang=zh_cn&edition=full","pubTime":"2025-06-19 10:46","pubTimestamp":1750301205,"startTime":"0","endTime":"0","summary":"美东时间2025年6月18日,Insmed Incorporated成交额为2.26亿美元,成交额较昨日减少16.35%,当日成交量为226.92万股。Insmed Incorporated于2025年6月18日跌0.82%,报99.46美元,该股过去5个交易日涨1.51%,年初至今涨44.06%,过去60日涨25.3%。|近5个交易日成交情况||||#|日期|成交额(美元)|成交额较昨日变化|成交量(股)|#|2025-06-18|2.26亿|-16.35%|226.92万|#|2025-06-17|2.70亿|-39.86%|268.47万|#|2025-06-16|4.49亿|-14.14%|447.88万|#|2025-06-13|5.23亿|-26.43%|532.16万|#|2025-06-12|7.11亿|-42.12%|729.99万|Insmed Inc是一家生物制药公司,致力于改变患有严重和罕见疾病的患者的生活。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250619104646a7119f7e&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250619104646a7119f7e&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LU0053671581.USD","LU0889565916.HKD","INSM","LU0109394709.USD","LU0320765992.SGD","BK4139"],"gpt_icon":0},{"id":"2543654776","title":"Insmed Incorporated6月13日成交额为5.23亿美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2543654776","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2543654776?lang=zh_cn&edition=full","pubTime":"2025-06-14 10:46","pubTimestamp":1749869190,"startTime":"0","endTime":"0","summary":"美东时间2025年6月13日,Insmed Incorporated成交额为5.23亿美元,成交额较昨日减少26.43%,当日成交量为532.16万股。Insmed Incorporated于2025年6月13日涨1.91%,报98.73美元,该股过去5个交易日涨34.11%,年初至今涨43.0%,过去60日涨25.07%。该公司还在开发Brensocatib,一种用于支气管扩张和其他中性粒细胞介导疾病的口服可逆二肽基肽酶1抑制剂以及Treprostinil Palmitil吸入粉剂,一种用于治疗与间质性肺病和肺动脉高压相关的肺动脉高压的吸入性treprostiil前药。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250614104636a4a88f5f&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250614104636a4a88f5f&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LU0053671581.USD","INSM","LU0889565916.HKD","LU0320765992.SGD","LU0109394709.USD","BK4139"],"gpt_icon":0},{"id":"2542507585","title":"Insmed Incorporated6月11日成交额为12.29亿美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2542507585","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2542507585?lang=zh_cn&edition=full","pubTime":"2025-06-12 10:37","pubTimestamp":1749695876,"startTime":"0","endTime":"0","summary":"美东时间2025年6月11日,Insmed Incorporated成交额为12.29亿美元,成交额较昨日减少13.03%,当日成交量为1274.45万股。Insmed Incorporated于2025年6月11日涨7.75%,报97.98美元,该股过去5个交易日涨32.96%,年初至今涨41.92%,过去60日涨25.99%。|近5个交易日成交情况||||#|日期|成交额(美元)|成交额较昨日变化|成交量(股)|#|2025-06-11|12.29亿|-13.03%|1274.45万|#|2025-06-10|14.13亿|930.39%|1571.15万|#|2025-06-09|1.37亿|17.92%|192.32万|#|2025-06-06|1.16亿|-42.61%|158.34万|#|2025-06-05|2.03亿|23.94%|276.81万|Insmed Inc是一家生物制药公司,致力于改变患有严重和罕见疾病的患者的生活。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250612103805a4a44926&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250612103805a4a44926&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LU0053671581.USD","LU0889565916.HKD","LU0109394709.USD","BK4139","LU0320765992.SGD","INSM"],"gpt_icon":0},{"id":"2542553534","title":"加拿大皇家银行:维持Insmed(INSM.US)评级,由优于大市调整至优于大市评级, 目标价由99.00美元调整至106.00美元。","url":"https://stock-news.laohu8.com/highlight/detail?id=2542553534","media":"金融界","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2542553534?lang=zh_cn&edition=full","pubTime":"2025-06-11 23:13","pubTimestamp":1749654804,"startTime":"0","endTime":"0","summary":"加拿大皇家银行:维持Insmed(INSM.US)评级,由优于大市调整至优于大市评级, 目标价由99.00美元调整至106.00美元。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://24h.jrj.com.cn/2025/06/11231351017077.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"jinrongjie_stock","symbols":["INSM"],"gpt_icon":0},{"id":"2542581326","title":"HC Wainwright & Co.:维持Insmed(INSM.US)评级,由买入调整至买入评级, 目标价由90.00美元调整至120.00美元。","url":"https://stock-news.laohu8.com/highlight/detail?id=2542581326","media":"金融界","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2542581326?lang=zh_cn&edition=full","pubTime":"2025-06-11 19:58","pubTimestamp":1749643101,"startTime":"0","endTime":"0","summary":"HC Wainwright & Co.:维持Insmed(INSM.US)评级,由买入调整至买入评级, 目标价由90.00美元调整至120.00美元。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://24h.jrj.com.cn/2025/06/11195851013623.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"jinrongjie_stock","symbols":["INSM"],"gpt_icon":0},{"id":"2542337857","title":"Insmed Incorporated6月10日成交额为14.13亿美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2542337857","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2542337857?lang=zh_cn&edition=full","pubTime":"2025-06-11 10:27","pubTimestamp":1749608856,"startTime":"0","endTime":"0","summary":"美东时间2025年6月10日,Insmed Incorporated成交额为14.13亿美元,成交额较昨日增加930.39%,当日成交量为1571.15万股。Insmed Incorporated于2025年6月10日涨28.65%,报90.93美元,该股过去5个交易日涨24.43%,年初至今涨31.71%,过去60日涨18.79%。|近5个交易日成交情况||||#|日期|成交额(美元)|成交额较昨日变化|成交量(股)|#|2025-06-10|14.13亿|930.39%|1571.15万|#|2025-06-09|1.37亿|17.92%|192.32万|#|2025-06-06|1.16亿|-42.61%|158.34万|#|2025-06-05|2.03亿|23.94%|276.81万|#|2025-06-04|1.64亿|18.67%|221.23万|Insmed Inc是一家生物制药公司,致力于改变患有严重和罕见疾病的患者的生活。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250611102746a4a2c42f&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250611102746a4a2c42f&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LU0889565916.HKD","LU0053671581.USD","LU0320765992.SGD","INSM","LU0109394709.USD","BK4139"],"gpt_icon":0},{"id":"2542347895","title":"Leerink Partners:维持Insmed(INSM.US)评级,由优于大市调整至优于大市评级, 目标价由100.00美元调整至115.00美元。","url":"https://stock-news.laohu8.com/highlight/detail?id=2542347895","media":"金融界","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2542347895?lang=zh_cn&edition=full","pubTime":"2025-06-11 03:43","pubTimestamp":1749584620,"startTime":"0","endTime":"0","summary":"Leerink Partners:维持Insmed(INSM.US)评级,由优于大市调整至优于大市评级, 目标价由100.00美元调整至115.00美元。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://24h.jrj.com.cn/2025/06/11034350990270.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"jinrongjie_stock","symbols":["INSM"],"gpt_icon":0},{"id":"2540082447","title":"Insmed Incorporated6月3日成交额为1.38亿美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2540082447","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2540082447?lang=zh_cn&edition=full","pubTime":"2025-06-04 10:24","pubTimestamp":1749003876,"startTime":"0","endTime":"0","summary":"美东时间2025年6月3日,Insmed Incorporated成交额为1.38亿美元,成交额较昨日减少21.33%,当日成交量为188.96万股。Insmed Incorporated于2025年6月3日涨1.95%,报73.08美元,该股过去5个交易日涨7.44%,年初至今涨5.85%,过去60日跌2.42%。|近5个交易日成交情况||||#|日期|成交额(美元)|成交额较昨日变化|成交量(股)|#|2025-06-03|1.38亿|-21.33%|188.96万|#|2025-06-02|1.75亿|-32.40%|245.25万|#|2025-05-30|2.59亿|104.64%|371.68万|#|2025-05-29|1.27亿|-56.88%|184.41万|#|2025-05-28|2.94亿|84.84%|439.57万|Insmed Inc是一家生物制药公司,致力于改变患有严重和罕见疾病的患者的生活。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250604102439a6f97f36&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250604102439a6f97f36&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LU0109394709.USD","LU0053671581.USD","BK4139","LU0320765992.SGD","INSM","LU0889565916.HKD"],"gpt_icon":0},{"id":"2540996748","title":"Insmed Incorporated6月2日成交额为1.75亿美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2540996748","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2540996748?lang=zh_cn&edition=full","pubTime":"2025-06-03 10:23","pubTimestamp":1748917406,"startTime":"0","endTime":"0","summary":"美东时间2025年6月2日,Insmed Incorporated成交额为1.75亿美元,成交额较昨日减少32.40%,当日成交量为245.25万股。Insmed Incorporated于2025年6月2日涨2.8%,报71.68美元,该股过去5个交易日涨6.15%,年初至今涨3.82%,过去60日跌4.45%。|近5个交易日成交情况||||#|日期|成交额(美元)|成交额较昨日变化|成交量(股)|#|2025-06-02|1.75亿|-32.40%|245.25万|#|2025-05-30|2.59亿|104.64%|371.68万|#|2025-05-29|1.27亿|-56.88%|184.41万|#|2025-05-28|2.94亿|84.84%|439.57万|#|2025-05-27|1.59亿|53.07%|233.05万|Insmed Inc是一家生物制药公司,致力于改变患有严重和罕见疾病的患者的生活。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250603102331a4977ec8&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250603102331a4977ec8&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LU0889565916.HKD","BK4139","LU0320765992.SGD","INSM","LU0053671581.USD","LU0109394709.USD"],"gpt_icon":0}],"profile":{"websiteUrl":"http://www.insmed.com","stockEarnings":[{"period":"1week","weight":-0.018},{"period":"1month","weight":0.3649},{"period":"3month","weight":0.4885},{"period":"6month","weight":0.4785},{"period":"1year","weight":0.3728},{"period":"ytd","weight":0.3973}],"compareEarnings":[{"period":"1week","weight":0.0058},{"period":"1month","weight":0.0407},{"period":"3month","weight":0.1896},{"period":"6month","weight":0.0751},{"period":"1year","weight":0.1228},{"period":"ytd","weight":0.0648}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"Insmed Incorporated是一家生物制药公司,专注于研发吸入疗法为患者对抗危及生命的肺部疾病。公司主打产品ARIKACE和阿米卡星脂质体吸入剂是一种吸入的抗生疗法,证明抗感染药在治疗肺部重感染疾病时能提升该疗法的效果,安全性阿和便利性。公司于1999年11月29日在英联邦弗吉尼亚州成立。","yearOnYearQuotes":[{"month":1,"riseRate":0.470588,"avgChangeRate":0.071463},{"month":2,"riseRate":0.411765,"avgChangeRate":0.079066},{"month":3,"riseRate":0.371429,"avgChangeRate":-0.053836},{"month":4,"riseRate":0.4,"avgChangeRate":0.04767},{"month":5,"riseRate":0.4,"avgChangeRate":0.067566},{"month":6,"riseRate":0.542857,"avgChangeRate":0.027147},{"month":7,"riseRate":0.457143,"avgChangeRate":0.001202},{"month":8,"riseRate":0.382353,"avgChangeRate":-0.030186},{"month":9,"riseRate":0.558824,"avgChangeRate":0.031309},{"month":10,"riseRate":0.411765,"avgChangeRate":-0.025331},{"month":11,"riseRate":0.647059,"avgChangeRate":0.105304},{"month":12,"riseRate":0.470588,"avgChangeRate":0.046817}],"exchange":"NASDAQ","name":"Insmed","nameEN":"Insmed"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.34.3","shortVersion":"4.34.3","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Insmed(INSM)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供Insmed(INSM)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"Insmed,INSM,Insmed股票,Insmed股票老虎,Insmed股票老虎国际,Insmed行情,Insmed股票行情,Insmed股价,Insmed股市,Insmed股票价格,Insmed股票交易,Insmed股票购买,Insmed股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Insmed(INSM)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供Insmed(INSM)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}